Skip to main content
Fig. 1 | Acta Neuropathologica Communications

Fig. 1

From: Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system

Fig. 1

Expression of IL-33 (brown) in healthy and MS brain patient samples. Immunohistochemical staining was used to determine the expression of IL-33 in the cortex and WM of healthy brain samples, and in the cortex, NAWM and lesion of acute and chronic MS patients. a cortex and d white matter of healthy brain tissues; b cortex, e NAWM and g lesion of acute MS brain sample; c cortex, f NAWM and h lesion of chronic MS brain sample

Back to article page